Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy

BACKGROUND: Clinical studies have suggested that prostate health index (phi) outperforms prostate-specific antigen (PSA) tests in prostate cancer detection. The cost-effectiveness of phi with different cutoffs is poorly understood in the context of decision making for prostate biopsy. METHODS: In a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Oncol
Egile Nagusiak: Huang, Da, Yang, Xiaoqun, Wu, Yishuo, Lin, Xiaoling, Xu, Danfeng, Na, Rong, Xu, Jianfeng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2020
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7732507/
https://ncbi.nlm.nih.gov/pubmed/33330035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.565382
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak